350325 <common-name>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(4-phenylmethoxyphenyl)acetamide</common-name> <description>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(4-phenylmethoxyphenyl)acetamide is a chemical compound with the formula C30H25ClN4O2S. With an average molecular weight of 541.10 g/mol, 2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(4-phenylmethoxyphenyl)acetamide is a heavy molecule.</description> <cas>476485-74-2</cas> <pubchem-id>1857065</pubchem-id> <chemical-formula>C30H25ClN4O2S</chemical-formula> <weight>541.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T15:19:43Z</created-at> <updated-at type="dateTime">2026-08-31T15:19:43Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CC1=CC=C(C=C1)N2C(=NN=C2SCC(=O)NC3=CC=C(C=C3)OCC4=CC=CC=C4)C5=CC=C(C=C5)Cl</moldb-smiles> <moldb-formula>C30H25ClN4O2S</moldb-formula> <moldb-inchi>InChI=1S/C30H25ClN4O2S/c1-21-7-15-26(16-8-21)35-29(23-9-11-24(31)12-10-23)33-34-30(35)38-20-28(36)32-25-13-17-27(18-14-25)37-19-22-5-3-2-4-6-22/h2-18H,19-20H2,1H3,(H,32,36)</moldb-inchi> <moldb-inchikey>JIKCVYDRVLHWKB-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">540.1386749</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM346218</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>2-[[5-(4-chlorophenyl)-4-(4-methylphenyl)-1,2,4-triazol-3-yl]sulfanyl]-n-(4-phenylmethoxyphenyl)acetamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Triazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0300632</sync-id> <structure-inchikey>JIKCVYDRVLHWKB-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4000200000800002100800000000000000000100000080005000000000000000000000200004008000002084000000000000000000000000200000000000000000400000000000000000000022000000000100000200000050000000000000010080000010000000000000840000000100000000000000000000000000000040220400800000000000000080880000010100000000000000000000000000000000000000000000080000000000000000490000000000002c00000000000000000000000000000000000000000010000000002000000220000000000000008140000000000040000000000480000000010000000040000000000020</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAmAAAAKgAAAIABBgBgAAAAAQMGQCgAAAAD BAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMB B0AoAAAAAwMGQCgAAAADBAdAKAAAAAMDB0AoAAAAAwMGQCgAAAADBBAAIAAA AAIGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHAGgAAAADAgEGQCgAAAADBAZA aAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAo AAAAAwIGAGAAAAACAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA AwMBBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAAD AwEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAREAIAAAAAELAAEAAQJoDAID aAwDBGgMBAVoDAUGaAwEByAHCGgMCAloDAkKaAwKC2gMCwwADA0ADQ4ADg8o Ag4QIBARIBESaAwSE2gMExRoDBQVaAwVFmgMFBcgFxgAGBkAGRpoDBobaAwb HGgMHB1oDB0eaAwIHyAfIGgMICFoDCEiaAwiI2gMIyRoDCIlAAYBaAwLB2gM FhFoDB4ZaAwkH2gMQgUAAAAGAQYFBAMCBQkIBwsKBhITFBUWEQYaGxwdHhkG ICEiIyQfFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:48:18Z</structure-indexed-at> </compound>